The DOI matches its Crossref record; 398 of the 398 references it cites were found in a registry or an index.
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Abstract
The past decades have witnessed hyperthermia therapy (HTT) as an emerging strategy against malignant tumors. Nanomaterial‐based photothermal therapy (PTT) and magnetic hyperthermia (MHT), as highly effective and noninvasive treatment models, offer advantages over other strategies in the treatment of different types of tumors. However, both PTT and MHT cannot completely cure cancer due to recurrence and distal metastasis. In recent years, cancer immunotherapy has attracted widespread attention owing to its capability to activate the body's own natural defense to identify, attack, and eradicate cancer cells. Significant efforts have been devoted to studying the activated immune responses caused by hyperthermia‐ablated tumors. In this article, the synergistic mechanism of HTT in immunotherapy, including immunogenic cell death and reversal of the immunosuppressive tumor microenvironment is discussed. The reports of the combination of HTT or HTT‐based multimodal therapy with immunotherapy, including immunoadjuvant exploitation, immune checkpoint blockade therapy, and adoptive cellular immunotherapy are summarized. As highlighted, these strategies could achieve synergistically enhanced therapeutic outcomes against both primary tumors and metastatic lesions, prevent cancer recurrence, and prolong the survival period. Finally, current challenges and prospective developments in HTT‐synergized immunotherapy are also reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–398 of 398
Adoptive Immunotherapy for Cancer or Viruses
Maus, M. V., Fraietta, J. A., Levine, B. L., Kalos, M., Zhao, Y., & June, C. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120136 · Cited by 264
Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
Taraseviciute, A., Tkachev, V., Ponce, R., Turtle, C. J., Snyder, J. M., Liggitt, H. D., Myerson, D., Gonzalez-Cuyar, L., Baldessari, A., English, C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1368 · Cited by 256
Noman, M. Z., Parpal, S., Van Moer, K., Xiao, M., Yu, Y., Arakelian, T., Viklund, J., De Milito, A., Hasmim, M., Andersson, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax7881 · Cited by 255
Wang, Z., Zhang, F., Shao, D., Chang, Z., Wang, L., Hu, H., Zheng, X., Li, X., Chen, F., Tu, Z., et al. (2019) · Advanced Science · doi:10.1002/advs.201901690 · Cited by 248
Yang, W., Zhang, F., Deng, H., Lin, L., Wang, S., Kang, F., Yu, G., Lau, J., Tian, R., Zhang, M., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b07212 · Cited by 248
Plasmonics of 2D Nanomaterials: Properties and Applications
Li, Y., Li, Z., Chi, C., Shan, H., Zheng, L., & Fang, Z. (2017) · Advanced Science · doi:10.1002/advs.201600430 · Cited by 245
Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy
Feng, B., Hou, B., Xu, Z., Saeed, M., Yu, H., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201902960 · Cited by 245
Nemunaitis, J., Sterman, D., Jablons, D., Smith, J. W., Fox, B., Maples, P., Hamilton, S., Borellini, F., Lin, A., Morali, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh028 · Cited by 244
T cell-mediated immunity to malaria
Kurup, S. P., Butler, N. S., & Harty, J. T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0158-z · Cited by 242
Advances in nanomedicine for cancer starvation therapy
Yu, S., Chen, Z., Zeng, X., Chen, X., & Gu, Z. (2019) · Theranostics · doi:10.7150/thno.38261 · Cited by 242
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Phillips, G. S., Wu, J., Hellmann, M. D., Postow, M. A., Rizvi, N. A., Freites-Martinez, A., Chan, D., Dusza, S., Motzer, R. J., Rosenberg, J. E., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02141 · Cited by 241
Integrins and T Cell–Mediated Immunity
Pribila, J. T., Quale, A. C., Mueller, K. L., & Shimizu, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104649 · Cited by 241
Immune checkpoint blockade in hematologic malignancies
Armand, P. (2015) · Blood · doi:10.1182/blood-2015-02-567453 · Cited by 238
Chen, Q., Huang, G., Wu, W., Wang, J., Hu, J., Mao, J., Chu, P. K., Bai, H., & Tang, G. (2020) · Advanced Materials · doi:10.1002/adma.201908185 · Cited by 236
Mansurov, A., Ishihara, J., Hosseinchi, P., Potin, L., Marchell, T. M., Ishihara, A., Williford, J.-M., Alpar, A. T., Raczy, M. M., Gray, L. T., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0549-2 · Cited by 235
Regulation of immune tolerance by anti-inflammatory neuropeptides
Gonzalez-Rey, E., Chorny, A., & Delgado, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri1984 · Cited by 233
Rheumatic immune-related adverse events from cancer immunotherapy
Calabrese, L. H., Calabrese, C., & Cappelli, L. C. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0074-9 · Cited by 233
Tumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
Dendritic cell-based immunotherapy: a basic review and recent advances
Constantino, J., Gomes, C., Falcão, A., Neves, B. M., & Cruz, M. T. (2017) · Immunologic Research · doi:10.1007/s12026-017-8931-1 · Cited by 228
Liu, X., Zheng, J., Sun, W., Zhao, X., Li, Y., Gong, N., Wang, Y., Ma, X., Zhang, T., Zhao, L.-Y., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01979 · Cited by 226
Chemotherapy medication errors
Weingart, S. N., Zhang, L., Sweeney, M., & Hassett, M. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30094-9 · Cited by 223
Yan, S., Zeng, X., Tang, Y., Liu, B., Wang, Y., & Liu, X. (2019) · Advanced Materials · doi:10.1002/adma.201905825 · Cited by 223
Chao, Y., Chen, G., Liang, C., Xu, J., Dong, Z., Han, X., Wang, C., & Liu, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00579 · Cited by 222
Zhang, Q., Guo, Q., Chen, Q., Zhao, X., Pennycook, S. J., & Chen, H. (2020) · Advanced Science · doi:10.1002/advs.201902576 · Cited by 222
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Fan, Y., Kuai, R., Xu, Y., Ochyl, L. J., Irvine, D. J., & Moon, J. J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03218 · Cited by 220
Elward, K. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00109-3 · Cited by 219
Zhang, D., Wu, T., Qin, X., Qiao, Q., Shang, L., Song, Q., Yang, C., & Zhang, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02903 · Cited by 218
Wu, W., Yu, L., Pu, Y., Yao, H., Chen, Y., & Shi, J. (2020) · Advanced Materials · doi:10.1002/adma.202000542 · Cited by 211
Luo, T., Ni, K., Culbert, A., Lan, G., Li, Z., Jiang, X., Kaufmann, M., & Lin, W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c02129 · Cited by 210
Jiang, X., Zhang, S., Ren, F., Chen, L., Zeng, J., Zhu, M., Cheng, Z., Gao, M., & Li, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b01032 · Cited by 206
Jia, Y. P., Shi, K., Yang, F., Liao, J. F., Han, R. X., Yuan, L. P., Hao, Y., Pan, M., Xiao, Y., Qian, Z. Y., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202001059 · Cited by 205
Antitumor immunologically modified carbon nanotubes for photothermal therapy
Zhou, F., Wu, S., Song, S., Chen, W. R., Resasco, D. E., & Xing, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.029 · Cited by 203
Calreticulin in the immune system: ins and outs
Raghavan, M., Wijeyesakere, S. J., Peters, L. R., & Del Cid, N. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.08.002 · Cited by 203
Molecular mechanisms of CD4+ T-cell anergy
Fathman, C. G., & Lineberry, N. B. (2007) · Nature Reviews Immunology · doi:10.1038/nri2131 · Cited by 203
ORAI2 modulates store-operated calcium entry and T cell-mediated immunity
Vaeth, M., Yang, J., Yamashita, M., Zee, I., Eckstein, M., Knosp, C., Kaufmann, U., Karoly Jani, P., Lacruz, R. S., Flockerzi, V., et al. (2017) · Nature Communications · doi:10.1038/ncomms14714 · Cited by 203
Hsp90 interaction with clients
Karagöz, G. E., & Rüdiger, S. G. D. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.12.002 · Cited by 202
de Gruijl, T. D., van den Eertwegh, A. J. M., Pinedo, H. M., & Scheper, R. J. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0536-z · Cited by 201
Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
Barsoum, I. B., Koti, M., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2598 · Cited by 201
Gao, A., Chen, B., Gao, J., Zhou, F., Saeed, M., Hou, B., Li, Y., & Yu, H. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04012 · Cited by 197
Chandrasekharan, P., Tay, Z. W., Hensley, D., Zhou, X. Y., Fung, B. K., Colson, C., Lu, Y., Fellows, B. D., Huynh, Q., Saayujya, C., et al. (2020) · Theranostics · doi:10.7150/thno.40858 · Cited by 197
Prendergast, G. C., Mondal, A., Dey, S., Laury-Kleintop, L. D., & Muller, A. J. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2017.11.005 · Cited by 196
Influence of nanomedicine mechanical properties on tumor targeting delivery
Li, Z., Xiao, C., Yong, T., Li, Z., Gan, L., & Yang, X. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00575g · Cited by 196
Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy
Champiat, S., Ferté, C., Lebel-Binay, S., Eggermont, A., & Soria, J. C. (2014) · OncoImmunology · doi:10.4161/onci.27817 · Cited by 192
Shi, C., Li, M., Zhang, Z., Yao, Q., Shao, K., Xu, F., Xu, N., Li, H., Fan, J., Sun, W., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119755 · Cited by 188
Yang, J., Hou, M., Sun, W., Wu, Q., Xu, J., Xiong, L., Chai, Y., Liu, Y., Yu, M., Wang, H., et al. (2020) · Advanced Science · doi:10.1002/advs.202001088 · Cited by 187
Ivkov, R., DeNardo, S. J., Daum, W., Foreman, A. R., Goldstein, R. C., Nemkov, V. S., & DeNardo, G. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0016 · Cited by 186
Zhang, Z., Kuang, G., Zong, S., Liu, S., Xiao, H., Chen, X., Zhou, D., & Huang, Y. (2018) · Advanced Materials · doi:10.1002/adma.201803217 · Cited by 186
Cancer immunotherapy and the value of cure
Del Paggio, J. C. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.27 · Cited by 184
He, L., Nie, T., Xia, X., Liu, T., Huang, Y., Wang, X., & Chen, T. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901240 · Cited by 184
Liu, X., Yan, B., Li, Y., Ma, X., Jiao, W., Shi, K., Zhang, T., Chen, S., He, Y., Liang, X.-J., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b08320 · Cited by 184
Innovative strategies for co-delivering antigens and CpG oligonucleotides
Krishnamachari, Y., & Salem, A. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.013 · Cited by 175
Chimeric antigen receptor signaling: Functional consequences and design implications
Lindner, S. E., Johnson, S. M., Brown, C. E., & Wang, L. D. (2020) · Science Advances · doi:10.1126/sciadv.aaz3223 · Cited by 175
Strong Red-Emitting near-Infrared-to-Visible Upconversion Fluorescent Nanoparticles
Yi, G., Peng, Y., & Gao, Z. (2011) · Chemistry of Materials · doi:10.1021/cm103175s · Cited by 174
Pan, J., Wang, Y., Zhang, C., Wang, X., Wang, H., Wang, J., Yuan, Y., Wang, X., Zhang, X., Yu, C., et al. (2018) · Advanced Materials · doi:10.1002/adma.201704408 · Cited by 174
Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo
Kooreman, N. G., Kim, Y., de Almeida, P. E., Termglinchan, V., Diecke, S., Shao, N.-Y., Wei, T.-T., Yi, H., Dey, D., Nelakanti, R., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.01.016 · Cited by 173
Yin, W., Bao, T., Zhang, X., Gao, Q., Yu, J., Dong, X., Yan, L., Gu, Z., & Zhao, Y. (2018) · Nanoscale · doi:10.1039/c7nr07927c · Cited by 168
Adoptive immunotherapy for cancer
Ruella, M., & Kalos, M. D. (2013) · Immunological Reviews · doi:10.1111/imr.12136 · Cited by 167
Inorganic Nanoshell-Stabilized Liquid Metal for Targeted Photonanomedicine in NIR-II Biowindow
Zhu, P., Gao, S., Lin, H., Lu, X., Yang, B., Zhang, L., Chen, Y., & Shi, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00364 · Cited by 167
Erratum: Targeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.110 · Cited by 167
Rong, L., Zhang, Y., Li, W.-S., Su, Z., Fadhil, J. I., & Zhang, C. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119515 · Cited by 167
Transplantation and Damage-Associated Molecular Patterns (DAMPs)
Land, W. G., Agostinis, P., Gasser, S., Garg, A. D., & Linkermann, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13963 · Cited by 163
Ultrathin 2D Rare‐Earth Nanomaterials: Compositions, Syntheses, and Applications
Xu, J., Chen, X., Xu, Y., Du, Y., & Yan, C. (2020) · Advanced Materials · doi:10.1002/adma.201806461 · Cited by 162
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants
van Hall, T., Wolpert, E. Z., van Veelen, P., Laban, S., van der Veer, M., Roseboom, M., Bres, S., Grufman, P., de Ru, A., Meiring, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1381 · Cited by 160
Protein Denaturation and Aggregation: Cellular Responses to Denatured and Aggregated Proteins
Meredith, S. C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1363.030 · Cited by 159
NIPSNAP1 and NIPSNAP2 Act as “Eat Me” Signals for Mitophagy
Princely Abudu, Y., Pankiv, S., Mathai, B. J., Håkon Lystad, A., Bindesbøll, C., Brenne, H. B., Yoke Wui Ng, M., Thiede, B., Yamamoto, A., Mutugi Nthiga, T., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.03.013 · Cited by 159
Gan, S., Tong, X., Zhang, Y., Wu, J., Hu, Y., & Yuan, A. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902757 · Cited by 159
Song, C., Phuengkham, H., Kim, Y. S., Dinh, V. V., Lee, I., Shin, I. W., Shin, H. S., Jin, S. M., Um, S. H., Lee, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11730-8 · Cited by 159
Zhang, M., Wang, W., Wu, F., Zheng, T., Ashley, J., Mohammadniaei, M., Zhang, Q., Wang, M., Li, L., Shen, J., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120106 · Cited by 159
Self-citationAutologous Dendritic Cell Vaccines for Non–Small-Cell Lung Cancer
Hirschowitz, E. A., Foody, T., Kryscio, R., Dickson, L., Sturgill, J., & Yannelli, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.074 · Cited by 158
Liu, Y., Yáng, Z., Huang, X., Yu, G., Wang, S., Zhou, Z., Shen, Z., Fan, W., Liu, Y., Davisson, M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02980 · Cited by 156
The reverse stop-signal model for CTLA4 function
Rudd, C. E. (2008) · Nature reviews. Immunology · doi:10.1038/nri2253 · Cited by 155
Immune checkpoint blockade therapy
Wieder, T., Eigentler, T., Brenner, E., & Röcken, M. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.042 · Cited by 150
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y. M., Kubo, K., Nakagawa, S., Nakanishi, M., Tanaka, K., & Mayumi, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00097-8 · Cited by 149
Multivalent Interactions between 2D Nanomaterials and Biointerfaces
Tu, Z., Guday, G., Adeli, M., & Haag, R. (2018) · Advanced Materials · doi:10.1002/adma.201706709 · Cited by 145
Zhou, B., Song, J., Wang, M., Wang, X., Wang, J., Howard, E. W., Zhou, F., Qu, J., & Chen, W. R. (2018) · Nanoscale · doi:10.1039/c8nr05323e · Cited by 145
Self-citationImmunopharmacologic Analysis of an Autologous, Hapten-Modified Human Melanoma Vaccine
Berd, D., Sato, T., Maguire, H., Kairys, J. C., & Mastrangelo, M. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.043 · Cited by 144
Triggering antitumoural drug release and gene expression by magnetic hyperthermia
Moros, M., Idiago-López, J., Asín, L., Antolín, E. M., Beola, L., Grazú, V., Fratila, R. M., Gutiérrez, L., & de la Fuente, J. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.004 · Cited by 144
Li, B., Hao, G., Sun, B., Gu, Z., & Xu, Z. P. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909745 · Cited by 143
Kono, K., Iinuma, H., Akutsu, Y., Tanaka, H., Hayashi, N., Uchikado, Y., Noguchi, T., Fujii, H., Okinaka, K., Fukushima, R., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-141 · Cited by 141
Peng, J., Yang, Q., Xiao, Y., Shi, K., Liu, Q., Hao, Y., Yang, F., Han, R., & Qian, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900004 · Cited by 139
Coupled partitioning of Au and As into pyrite controls formation of giant Au deposits
Kusebauch, C., Gleeson, S. A., & Oelze, M. (2019) · Science Advances · doi:10.1126/sciadv.aav5891 · Cited by 139
Ma, X., Wang, Y., Liu, X., Ma, H., Li, G., Li, Y., Gao, F., Peng, M., Fan, H., & Liang, X. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00233b · Cited by 139
Augmenting Tumor‐Starvation Therapy by Cancer Cell Autophagy Inhibition
Yang, B., Ding, L., Chen, Y., & Shi, J. (2020) · Advanced Science · doi:10.1002/advs.201902847 · Cited by 139
Magnetic hyperthermia enhances cell toxicity with respect to exogenous heating
Sanz, B., Calatayud, M. P., Torres, T. E., Fanárraga, M. L., Ibarra, M. R., & Goya, G. F. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.008 · Cited by 138
Wang, H., Pan, X., Wang, X., Wang, W., Huang, Z., Gu, K. X., Liu, S., Zhang, F., Shen, H., Yuan, Q., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b06168 · Cited by 138
Zhang, H., Zhang, J., Li, Q., Song, A., Tian, H., Wang, J., Li, Z., & Luan, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119983 · Cited by 138
The market for chimeric antigen receptor T cell therapies
Yip, A., & Webster, R. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.266 · Cited by 137
Combination therapy in multiple sclerosis
Conway, D. S., & Cohen, J. A. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70007-7 · Cited by 137
Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
Zhang, C., Gao, F., Wu, W., Qiu, W., Zhang, L., Li, R., Zhuang, Z., Yu, W., Cheng, H. L., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.9b04315 · Cited by 136
Yan, M., Liu, Y., Zhu, X., Wang, X., Liu, L., Sun, H., Wang, C., Kong, D., & Ma, G. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18751 · Cited by 134
Wen, Y., Chen, X., Zhu, X., Gong, Y., Yuan, G., Qin, X., & Liu, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b17137 · Cited by 134
Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment
David, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.006 · Cited by 133
Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines
Qin, S., Zhang, A., & Zhang, X. (2018) · Small · doi:10.1002/smll.201802417 · Cited by 133
Dong, X., Liang, J., Yang, A., Qian, Z., Kong, D., & Lv, F. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.024 · Cited by 133
Guo, Y., Ran, Y., Wang, Z., Cheng, J., Cao, Y., Yang, C., Liu, F., & Ran, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119370 · Cited by 133
Chen, Q., Liu, L., Lü, Y., Chen, X., Zhang, Y., Zhou, W., Guo, Q., Li, C., Zhang, Y., Zhang, Y. X., et al. (2019) · Advanced Science · doi:10.1002/advs.201802134 · Cited by 132
Self-citationToxicity of inorganic nanomaterials in biomedical imaging
Li, J., Chang, X., Chen, X., Gu, Z., Zhao, F., Chai, Z., & Zhao, Y. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.12.009 · Cited by 130
Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers
Song, Y., Barry, W. T., Seah, D. S. E., Tung, N., Garber, J. E., & Lin, N. (2019) · Cancer · doi:10.1002/cncr.32540 · Cited by 130
Kampinga, H. H., Brunsting, J. F., Stege, G. J. J., Burgman, P., & Konings, A. W. T. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1262 · Cited by 129
Magnetic mesoporous silica spheres for hyperthermia therapy
Martín-Saavedra, F. M., Ruíz-Hernández, E., Boré, A., Arcos, D., Vallet‐Regí, M., & Vilaboa, N. E. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.06.030 · Cited by 129
Toward Biomaterials for Enhancing Immune Checkpoint Blockade Therapy
Fan, Q., Chen, Z., Wang, C., & Liu, Z. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802540 · Cited by 129
Wu, J., Li, S., & Wei, H. (2018) · Nanoscale Horizons · doi:10.1039/c8nh00070k · Cited by 128
Chen, P.-M., Pan, W., Wu, C.-Y., Yeh, C.-Y., Korupalli, C., Luo, P.-K., Chou, C.-J., Chia, W., & Sung, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119629 · Cited by 128
Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition
Ye, H., Wang, K., Qi, L., Zhao, J., Wang, M., Kan, Q., Zhang, H., Wang, Y., He, Z., & Sun, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119932 · Cited by 128
Self-citationMechanisms of Immune Tolerance in Leukemia and Lymphoma
Curran, E. K., Godfrey, J. K., & Kline, J. P. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.004 · Cited by 127
Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
Alloatti, A., Rookhuizen, D. C., Joannas, L. D., Carpier, J.-M., Iborra, S., Magalhaes, J. G., Yatim, N., Kozik, P., Sancho, D., Albert, M. L., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170229 · Cited by 126
State-of-the-art iron-based nanozymes for biocatalytic tumor therapy
Li, M., Zhang, H., Hou, Y., Wang, X., Xue, C., Li, W., Cai, K., Zhao, Y., & Luo, Z. Y. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00577c · Cited by 125
Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy
Fang, R. H., Kroll, A. V., & Zhang, L. (2015) · Small · doi:10.1002/smll.201501284 · Cited by 124
Luo, L., Yang, J., Zhu, C., Jiang, M., Guo, X., Li, W., Yin, X., Yin, H., Qin, B., Yuan, X., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.002 · Cited by 123
Dendritic cells in cancer immunotherapy
Gall, C. M. L., Weiden, J., Eggermont, L. J., & Figdor, C. G. (2018) · Nature Materials · doi:10.1038/s41563-018-0093-6 · Cited by 123
Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells
Wang, R., & Wang, H. Y. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-149 · Cited by 122
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'
Teachey, D. T., Bishop, M. R., Maloney, D. G., & Grupp, S. A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.19 · Cited by 121
Combinatorial immunotherapy and nanoparticle mediated hyperthermia
Moy, A. J., & Tunnell, J. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.008 · Cited by 120
Zhang, X., Angsantikul, P., Man, Y. M., Zhuang, J., Zhang, Q., Wei, X., Jiang, Y., Zhang, Y., Dehaini, D., Chen, M., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707598 · Cited by 118
Jia, H., Zhu, Y., Liu, X., Pan, G., Gao, G., Sun, W., Zhang, X., Jiang, Y., & Wu, F. (2019) · ACS Nano · doi:10.1021/acsnano.9b05749 · Cited by 118
Nam, G., Lee, E. J., Kim, Y. K., Hong, Y., Choi, Y., Ryu, M., Woo, J., Cho, Y., Ahn, D. J., Yang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04607-9 · Cited by 117
Li, Z., Hu, Y., Fu, Q., Liu, Y., Wang, J., Song, J., & Yang, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201905758 · Cited by 116
Nierkens, S., den Brok, M. H., Garcia, Z., Togher, S., Wagenaars, J. A. L., Wassink, M., Boon, L., Ruers, T. J. M., Figdor, C. G., Schoenberger, S. P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2154 · Cited by 114
Yan, H., Shang, W., Sun, X., Zhao, L., Wang, J., Xiong, Z., Yuan, J., Zhang, R., Huang, Q., Wang, K., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201705710 · Cited by 112
Lammers, T., & Mauro Ferrari, B. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100853 · Cited by 111
Differential signaling by CpG DNA in DCs and B cells: not just TLR9
Verthelyi, D. I., & Zeuner, R. A. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00243-6 · Cited by 110
Innate immunity in transplant tolerance and rejection
Murphy, S. P., Porrett, P. M., & Turka, L. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01009.x · Cited by 103
Tumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy
Zhang, M., Li, C., Wang, S., Liu, T., Song, X., Yang, X., Feng, J. X., & Zhang, X. (2018) · Small · doi:10.1002/smll.201803602 · Cited by 103
Self-citationLipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
Wilson, K. D., de Jong, S. D., & Tam, Y. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.014 · Cited by 102
van Kooyk, Y., Appelmelk, B. J., & Geijtenbeek, T. B. H. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00027-3 · Cited by 101
Albumin-biomineralized nanoparticles to synergize phototherapy and immunotherapy against melanoma
Zhu, Y., Xue, J., Chen, W., Bai, S., Zheng, T., He, C., Guo, Z., Jiang, M. L., Du, G., & Sun, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.045 · Cited by 101
Dendritic Cells in Antifungal Immunity and Vaccine Design
Roy, R. M., & Klein, B. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.005 · Cited by 99
Zhou, F., Yang, J., Zhang, Y., Liu, M., Lang, M. L., Li, M., & Chen, W. R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1126 · Cited by 98
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread
Ma, Q., Dieterich, L. C., Ikenberg, K., Bachmann, S. B., Mangana, J., Proulx, S. T., Amann, V. C., Levesque, M. P., Dummer, R., Bałuk, P., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat4758 · Cited by 98
Wang, J., Chang, Y., Luo, H., Jiang, W., Xu, L., Chen, T., & Zhu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120153 · Cited by 98
Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer
Ramakrishnan, R., & Gabrilovich, D. I. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1390-6 · Cited by 97
The application of nanotechnology in immune checkpoint blockade for cancer treatment
Deng, H., & Zhang, Z. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.026 · Cited by 97
Han, X., Wang, R., Xu, J., Chen, Q., Liang, C., Chen, J., Zhao, J., Chu, J., Fan, Q., Ogunnaike, E. A., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119490 · Cited by 92
Zhang, L., Cheng, Q., Li, C., Zeng, X., & Zhang, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120029 · Cited by 92
Self-citationDelivery Strategies for Immune Checkpoint Blockade
Chen, Q., Wang, C., Chen, G., Hu, Q., & Gu, Z. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800424 · Cited by 90
Li, Y., Ayala‐Orozco, C., Rauta, P. R., & Krishnan, S. (2019) · Nanoscale · doi:10.1039/c9nr05371a · Cited by 88
Chen, Y., Zhang, Y., Chen, M., Zhuang, J., Fang, R. H., Gao, W., & Zhang, L. (2019) · Small · doi:10.1002/smll.201804994 · Cited by 87
Traceless aptamer-mediated isolation of CD8+ T cells for chimeric antigen receptor T-cell therapy
Kacherovsky, N. A., Cardle, I. I., Cheng, E. L., Yu, J. L., Baldwin, M. L., Salipante, S. J., Jensen, M. C., & Pun, S. H. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0411-6 · Cited by 87
Li, M., Wong, N.-K., Xiao, J., Zhu, R., Wu, L., Dai, S., Chen, F., Huang, G., Xu, L., Bai, X., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10235 · Cited by 86
Xu, C., Yu, Y., Sun, Y., Kong, L., Yang, C., Hu, M. Y., Yang, T., Zhang, J., Hu, Q., & Zhang, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201905213 · Cited by 84
Sun, X., Cao, Z., Mao, K., Wu, C., Chen, H., Wang, J., Wang, X., Cong, X., Li, Y., Meng, X., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119845 · Cited by 83
Engineering Immune Tolerance with Biomaterials
Gammon, J. M., & Jewell, C. M. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801419 · Cited by 80
Human mast cells present antigen to autologous CD4+ T cells
Lotfi‐Emran, S., Ward, B. R., Le, Q. T., Pozez, A. L., Manjili, M. H., Woodfolk, J. A., & Schwartz, L. B. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.02.048 · Cited by 79
Recent advances in applying nanotechnologies for cancer immunotherapy
Mahjub, R., Jatana, S., Lee, S. E., Qin, Z., Pauli, G., Soleimani, M., Madadi, S., & Li, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.010 · Cited by 77
Escape from immune- and nonimmune-mediated tumor surveillance.
Malmberg, K., & Ljunggren, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.007 · Cited by 76
Yu, P., Spiotto, M. T., Lee, Y., Schreiber, H. W., & Fu, Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021804 · Cited by 75
The Immune Tolerance Network at 10 years: tolerance research at the bedside
Bluestone, J. A., Auchincloss, H., Nepom, G. T., Rotrosen, D., Clair, E. W. S., & Turka, L. A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2869 · Cited by 70
Hyperfine-phonon spin relaxation in a single-electron GaAs quantum dot
Camenzind, L. C., Yu, L., Stano, P., Zimmerman, J. D., Gossard, A. C., Loss, D., & Zumbühl, D. M. (2018) · Nature Communications · doi:10.1038/s41467-018-05879-x · Cited by 70
Wan, S., Zhang, B., Li, S., He, B., & Pu, Y. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00434k · Cited by 70
Immunotherapy of distant metastatic disease
Schadendorf, D., Martín‐Algarra, S., Bastholt, L., Cinat, G., Dréno, B., Eggermont, A. M. M., Espinosa, E., Guo, J., Hauschild, A., Petrella, T. M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp253 · Cited by 65
Gorbet, M.-J., & Ranjan, A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107456 · Cited by 65
Ming, J., Zhang, J., Shi, Y., Yang, W., Li, J., Sun, D., Xiang, S., Chen, X., Chen, L., & Zheng, N. (2020) · Nanoscale · doi:10.1039/c9nr09402d · Cited by 65
Su, Y., Wang, T., Su, Y., Li, M., Zhou, J., Zhang, W., & Wang, W. (2019) · Materials Horizons · doi:10.1039/c9mh01068h · Cited by 64
Nanomaterials for Combinational Radio–Immuno Oncotherapy
Wang, J., Li, Z., Wang, Z., Yu, Y., Li, D., Li, B., & Ding, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910676 · Cited by 63
Immunotherapy with dendritic cells for cancer
Ballestrero, A., Boy, D., Morán, E., Cirmena, G., Brossart, P., & Nencioni, A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.026 · Cited by 62
Yang, J., & Zhang, C. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1612 · Cited by 62
IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery
Qian, S., Zhang, M., Chen, Q., He, Y., Wang, W., & Wang, Z. (2016) · RSC Advances · doi:10.1039/c5ra25046c · Cited by 61
Hong, E., & Dobrovolskaia, M. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.005 · Cited by 61
Cervadoro, A., Cho, M., Key, J., Cooper, C. L., Stigliano, C., Aryal, S., Brazdeikis, A., Leary, J. F., & Decuzzi, P. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am504270c · Cited by 60
Chang, M., Wang, M., Chen, Y., Shu, M., Zhao, Y., Ding, B., Hou, Z., & Lin, J. (2019) · Nanoscale · doi:10.1039/c9nr02412c · Cited by 60
Self-citationXu, J., Saklatvala, R., Mittal, S., Deshmukh, S., & Procopio, A. T. (2020) · Advanced Science · doi:10.1002/advs.201903394 · Cited by 59
IRAP+ endosomes restrict TLR9 activation and signaling
Babdor, J., Descamps, D., Adiko, A. C., Tohmé, M., Maschalidi, S., Evnouchidou, I., Vasconcellos, L. R. C., Luca, M. D., Mauvais, F., Garfa‐Traoré, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3711 · Cited by 57
Wu, Q., Yu, J., Li, M., Tan, L., Ren, X., Fu, C., Chen, Z., Cao, F., Ren, J., Li, L., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.041 · Cited by 57
Evolution of immune surveillance and tumor immunity: studies in Xenopus
Robert, J., & Cohen, N. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01266.x · Cited by 56
Anisotropic functionalization of upconversion nanoparticles
Ren, W., Wen, S., Tawfik, S. A., Su, Q. P., Lin, G., Ju, L. A., Ford, M. J., Ghodke, H. B., van Oijen, A. M., & Jin, D. (2018) · Chemical Science · doi:10.1039/c8sc01023d · Cited by 51
Immune surveillance, organophosphorus exposure, and lymphomagenesis
Newcombe, D. S. (1992) · The Lancet · doi:10.1016/0140-6736(92)90349-8 · Cited by 43
CpG oligodeoxynucleotide-based therapy of lymphoid malignancies
Weiner, G. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.006 · Cited by 43
Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
Abdalla, A. M. E., Xiao, L. J., Miao, Y., Huang, L., Fadlallah, G. M., Gauthier, M., Ouyang, C., & Yang, G. (2020) · Advanced Science · doi:10.1002/advs.201903164 · Cited by 43
Yang, Y., Nam, G., Kim, G. B., Kim, Y. K., & Kim, I. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.007 · Cited by 40
Han, C., Sim, S.-J., Kim, S.-H., Singh, R., Hwang, S., Kim, Y. I., Park, S. H., Kim, K. H., Lee, D. G., Oh, H. S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02912-x · Cited by 39
Immune Checkpoint Blockade across the Cancer Care Continuum
Helmink, B. A., Gaudreau, P.-O., & Wargo, J. A. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.003 · Cited by 39
Functional T cell activation by smart nanosystems for effective cancer immunotherapy
Yang, W., Zhou, Z., Lau, J., Hu, S., & Chen, X. S. (2019) · Nano Today · doi:10.1016/j.nantod.2019.05.004 · Cited by 39
Advancements in immune tolerance
Pan, P., Ozao, J. J., Zhou, Z., & Chen, S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.025 · Cited by 38
Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2
Oh, Y. M., Park, H. B., Shin, J. H., Lee, J. E., Park, H. Y., Kho, D. H., Lee, J. S., Choi, H., Okuda, T., Kokame, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms9698 · Cited by 37
Song, Y., Wang, Y., Wang, S., Cheng, Y. S., Lu, Q., Yang, L., Tan, F., & Li, N. (2019) · Nano Research · doi:10.1007/s12274-019-2341-8 · Cited by 36
Wu, Y., Li, J., Kaboli, P. J., Shen, J., Wu, X., Zhao, Y., Ji, H., Du, F., Zhou, Y., Wang, Y., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104691 · Cited by 36
Hu, C. J., & Zhang, L. (2014) · Nano Today · doi:10.1016/j.nantod.2014.06.001 · Cited by 35
Overcoming Acquired PD-1/PD-L1 Resistance with CD38 Blockade
Mittal, D., Vijayan, D., & Smyth, M. J. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0798 · Cited by 34
Challenges in the pursuit of immune tolerance
Nepom, G. T., Clair, E. W. S., & Turka, L. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01003.x · Cited by 29
Du, J., Wang, X., Dong, X., Zhang, C., Mei, L., Zang, Y., Yan, L., Zhang, H., & Gu, Z. (2019) · Nanoscale · doi:10.1039/c8nr09618j · Cited by 28
Immunobiology of chimeric antigen receptor T cells and novel designs
Walsh, Z. H., Yang, Y., & Kohler, M. E. (2019) · Immunological Reviews · doi:10.1111/imr.12794 · Cited by 28
Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
Zhang, M., Liu, K., & Wang, M. (2019) · RSC Advances · doi:10.1039/c9ra04590b · Cited by 26
Self-citationEngineering primary T cells with chimeric antigen receptors for rewired responses to soluble ligands
Chang, Z., Hou, A. J., & Chen, Y. Y. (2020) · Nature Protocols · doi:10.1038/s41596-020-0294-8 · Cited by 26
The STATs on Dendritic Cell Development
Onai, N., & Manz, M. G. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.006 · Cited by 25
An immunosuppressive pathway for tumor progression
Marçais, A., & Walzer, T. (2018) · Nature Medicine · doi:10.1038/nm.4508 · Cited by 24
Mahmood, J., Alexander, A. A., Samanta, S., Kamlapurkar, S., Singh, P., Saeed, A., Carrier, F., Cao, X., Shukla, H. D., & Vujašković, Ž. (2020) · Cancers · doi:10.3390/cancers12041015 · Cited by 22
Antigen-specific immune tolerance in the liver
Doherty, D. G. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0445-9 · Cited by 21
Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers
Segovia, M., Russo, S., Girotti, M. R., Rabinovich, G. A., & Hill, M. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13433 · Cited by 20
Turn Off the IDO: Will Clinical Trials Be Successful?
Novitskiy, S. V., & Moses, H. L. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0311 · Cited by 12
Jin, J., Peng, W. L., Tang, S. Q., Rong, M. Z., & Zhang, M. Q. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02129e · Cited by 12
THINNES, F. P. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.02.001 · Cited by 10
The Architects of B and T Cell Immune Responses
Lane, P. J. L. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.005 · Cited by 8
Stem Cells Cycle toward Immune Surveillance
Boyd, A. S., & Rodrigues, N. P. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.006 · Cited by 8
Science without boundary: interdisciplinary research
Lu, G. Q. (2016) · National Science Review · doi:10.1093/nsr/nww021 · Cited by 6
Wrighton, K. H. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0092-6 · Cited by 6
Translational Medicine: Insights from Interdisciplinary Graduate Research Training
Lamb, J. A., & Curtin, J. A. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.12.003 · Cited by 5
Immune checkpoint inhibitors for refractory childhood cancers
Widemann, B. C. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30777-6 · Cited by 5
A Calreticulin Tail: C-terminal Mutants of Calreticulin Allow Cancer Cells to Evade Phagocytosis
Kaur, A., & Raghavan, M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.024 · Cited by 5
Cited by
Li, Z., Lai, X., Fu, S., Ren, L., Cai, H., Zhang, H., Gu, Z., Ma, X., & Luo, K. (2022) · Advanced Science · doi:10.1002/advs.202201734 · Cited by 680
Phototherapy in cancer treatment: strategies and challenges
Cai, Y., Chai, T., Nguyen, W., Liu, J., Xiao, E., Ran, X., Ran, Y., Du, D., Chen, W., & Chen, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02140-y · Cited by 453
Ouyang, J., Xie, A., Zhou, J., Liu, R., Wang, L., Liu, H., Kong, N., & Tao, W. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01148k · Cited by 385
Immunogenic Cell Death Induction by Ionizing Radiation
Zhu, M., Yang, M., Zhang, J., Yin, Y., Fan, X., Zhang, Y., Qin, S., Zhang, H., & Yu, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705361 · Cited by 291
Multifunctional Magnetic Nanoparticles for Dynamic Imaging and Therapy
Ko, M. J., Hong, H., Choi, H., Kang, H., & Kim, D. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200053 · Cited by 29
Metadata
- Authors
- Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-12-02
- Volume
- 33
- Issue
- 4
- Pages
- e2004788-e2004788
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W3108735200
- Cited by
- 450
- References
- 398
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.